BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ·Healthcare·Biotechnology
$53.31
-0.92%
Mkt Cap $10.50B
Analyst Ratings
Buy
13
Hold
4
Sell
0
Price Target (59 analysts)
$86.60
Range $60.00 – $105.00
Implied Upside
+62.4%
Consensus $86.60 vs current $53.31
NASDAQ·Healthcare·Biotechnology
$53.31
-0.92%
Mkt Cap $10.50B
Buy
13
Hold
4
Sell
0
Price Target (59 analysts)
$86.60
Range $60.00 – $105.00
+62.4%
Consensus $86.60 vs current $53.31